These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7954595)

  • 1. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
    Przyklenk K; Bauer B; Ovize M; Kloner RA; Whittaker P
    Circulation; 1993 Mar; 87(3):893-9. PubMed ID: 7680290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
    Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcardiac alteration of neutrophil function relates to myocardial ischaemia/reperfusion injury.
    Hoshida S; Kuzuya T; Fuji H; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1993 Mar; 27(3):377-83. PubMed ID: 8490937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Mar; 29(3):401-6. PubMed ID: 7781014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.
    Li Y; Kloner RA
    Circulation; 1993 May; 87(5):1642-8. PubMed ID: 8491020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
    Walsh RS; Tsuchida A; Daly JJ; Thornton JD; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Sep; 28(9):1337-41. PubMed ID: 7954642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic preconditioning of ischaemic canine myocardium.
    Shizukuda Y; Mallet RT; Lee SC; Downey HF
    Cardiovasc Res; 1992 May; 26(5):534-42. PubMed ID: 1446323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acadesine extends the window of protection afforded by ischaemic preconditioning.
    Tsuchida A; Yang XM; Burckhartt B; Mullane KM; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Mar; 28(3):379-83. PubMed ID: 8174159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced antiarrhythmic effects of preconditioning in anaesthetized dogs: is adenosine involved?
    Vegh A; Papp JG; Parratt JR
    J Mol Cell Cardiol; 1995 Jan; 27(1):349-56. PubMed ID: 7760356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Vander Heide RS; Schwartz LM; Reimer KA
    Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning.
    Miura T; Suzuki K; Shimamoto K; Iimura O
    Basic Res Cardiol; 1996; 91(6):425-32. PubMed ID: 8996627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.